Metffil VG 2 Tablet SR: A Combined Approach to Blood Sugar Management

Metffil VG 2 Tablet SR is a combination oral medication used to effectively manage blood sugar levels in adults with Type 2 diabetes. This fixed-dose tablet formulation combines three active ingredients for optimal efficacy:

* Glimepiride (2mg): A sulfonamide derivative that stimulates the release of insulin from the pancreas, leading to improved glucose uptake by cells.
* Metformin (500mg): A first-line medication for type 2 diabetes, primarily acting on the liver to reduce hepatic glucose production and enhancing cellular sensitivity to insulin.
* Voglibose (0.2mg): A specific alpha-glucosidase inhibitor that slows down carbohydrate digestion and absorption in the gut, thus reducing postprandial blood glucose spikes.

The combination of these ingredients provides a comprehensive approach to controlling both fasting and post-meal blood sugar levels.

Metffil VG 2 Tablet SR is recommended for patients who have not achieved satisfactory glycemic control with monotherapy and are not contraindicated for this medication regimen.

Please note: This description should not be considered as medical advice. Consult your healthcare provider regarding the proper dosage and suitability of this medication for your specific needs.